ERBB2 and neoplasm: To understand how disseminated tumor cells persist as subclinical disease and initiate metachronous metastasis, we performed in vivo phenotypic selection in mice and isolated latent brain metastatic (Lat) cells from HCC1954 and SKBR3 HER2+ breast cancer cells6,23–25.